TB-500

Each TB-500 batch released by Vertex Labs is supported by batch-level documentation and Certificate of Analysis availability following quality review. Documentation may include identity confirmation, purity assessment, active weight verification, labeling review, and other analytical information relevant to the specific research batch.

Review available batch documentation through the
Vertex Labs COA database.
Additional information regarding laboratory review procedures, documentation standards, and quality controls is available on our
Testing Standards page.

TB-500 should be handled using established laboratory practices and appropriate internal quality procedures. Personnel should review the selected strength, product labeling, batch-specific documentation, container condition, and applicable storage requirements before use in a controlled laboratory environment.

Keep the vial sealed until required for laboratory preparation and store the material according to the conditions specified on the product label. Laboratories should maintain appropriate handling, documentation, and material-control procedures for their research environment.

TB-500 is identified by its defined synthetic peptide fragment sequence and associated molecular characteristics. These identifiers help distinguish the material from other thymosin beta-4-related research compounds and support accurate documentation within controlled laboratory environments.

Researchers should verify the selected strength, vial labeling, batch number, sequence information, and corresponding analytical documentation before use. Maintaining clear material identification and batch traceability supports consistency across individual laboratory workflows.